Today: 2 July 2026

Rocket Lab stock drops again today: RKLB slides as SpaceX-xAI buzz fades, Mars funding in focus

Rocket Lab stock drops again today: RKLB slides as SpaceX-xAI buzz fades, Mars funding in focus

NEW YORK, Feb 5, 2026, 12:14 — Regular session underway. Shares of Rocket Lab Corporation dropped nearly 6% on Thursday, hovering around $69 as the stock continued its recent slide affecting several space-related companies this week. By roughly 12:15 p.m. EST, the Nasdaq-listed stock was down 5.9% at $68.74, with about 11 million shares changing hands. This followed a 10% plunge in the previous session, according to MarketScreener data.
Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

Hims & Hers (HIMS) stock whipsaws on $49 “compounded Wegovy pill” plan as Novo Nordisk threatens legal action

New York, February 5, 2026, 11:30 AM EST — Regular session Shares of Hims & Hers Health Inc swung sharply Thursday following the company’s announcement that it plans to offer a low-cost compounded version of Novo Nordisk’s new Wegovy weight-loss pill. Novo Nordisk promptly threatened legal action. The stock bounced back to $24.41 in late morning trading after earlier surging to $29.44.
Alphabet’s up to $185 billion AI capex plan hits Wall Street as Nasdaq slides again

Alphabet’s up to $185 billion AI capex plan hits Wall Street as Nasdaq slides again

Wall Street dipped again Thursday, dragged down by tech stocks as worries resurfaced over the costs tied to AI development, with Alphabet and Qualcomm leading the declines. At 9:41 a.m. ET, the Dow was off 0.56%, the S&P 500 had fallen 0.51%, and the Nasdaq slipped 0.50%. Alphabet dropped 2.6%, while Qualcomm plunged about 8%. Melissa Brown from SimCorp called the AI trade “perhaps the extinguisher this year.” Concerns center on capital spending — or “capex” as traders call it — the money firms pump into data centers, chips, and servers to build and operate AI models. Alphabet told investors it plans to spend between $175 billion and $185 billion on capex in 2026. CEO Sundar Pichai said, “We are seeing our AI investments and infrastructure drive revenue and growth across the board.”
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

New York, February 5, 2026, 11:03 EST — Regular session The Cigna Group’s shares jumped about 3.2% to $280.46 in late morning trading Thursday after it unveiled quarterly results and its 2026 outlook. UnitedHealth slipped nearly 1.6%, CVS Health rose close to 2.2%, and Elevance slipped around 0.7%. CI stock traded in a range from $270.00 up to $283.59.
QQQ Slides Again as Alphabet’s $185B AI Spend Plan Stirs Nasdaq-100 ETF Jitters

QQQ Slides Again as Alphabet’s $185B AI Spend Plan Stirs Nasdaq-100 ETF Jitters

Invesco QQQ Trust, the widely traded Nasdaq-100 ETF, dropped roughly 1.6% Thursday morning, following continued selling pressure in big tech after a steep decline the previous day. The Nasdaq-100 ETF acts as a fast barometer for U.S. growth stocks, often jolting when investors pivot between “risk-on” and “risk-off” stances — moving toward safer holds like cash, bonds, or defensive picks. This week’s action has been propelled by earnings news and fresh arguments about whether AI spending is accelerating too rapidly and excessively.

Stock Market Today

  • Tesla Slides 8% Even After Q2 Deliveries Beat Estimates
    July 2, 2026, 2:51 PM EDT. Tesla shares dropped 8% Thursday, even though the company delivered 480,126 vehicles in Q2, topping analysts' average prediction of 406,000, according to an SEC filing. Q2 deliveries climbed from 358,000 in Q1, led by a sharp sales rebound in Europe-up 77% through May. The stock move came after Michael Burry disclosed a short position against Tesla, betting at $416.22 per share. Tesla has dropped the Model S and Model X lines, turning its focus to Models 3, Y, and Cybertruck. Elon Musk lost more than $14 billion in net worth as the share fall and flat SpaceX stock knocked him out of the trillionaire ranks. Tesla's quarter played out against criticism from European officials and news of a deadly Tesla semi crash.
Go toTop